NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19 | NIH: National Institute of Allergy and Infectious Diseases

Wednesday, April 29, 2020 NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19 A preliminary data analysis from an NIH clinical trial shows hospitalized patients with advanced COVID-19 and lung involvement who received the investigational antiviral drug remdesivir recovered faster than similar patients who received placebo.